A convergent total synthesis of (+)-mycalamide A is described. A Yb(OTf)(3)-TMSCI catalytic system is used to synthesize a trioxadecalin ring system, which contains the right segment of mycalamide A. In addition, a tetrallydropyran ring, which is the left segment, is constructed with use of a novel one-pot delta-lactonization protocol. Both segments are prepared from a common starting material, D-mannitol. These segments are then coupled and the functional groups are transformed to synthesize (+)-mycalamide A.
A convergent total synthesis of (+)-mycalamide A is described. A Yb(OTf)(3)-TMSCI catalytic system is used to synthesize a trioxadecalin ring system, which contains the right segment of mycalamide A. In addition, a tetrallydropyran ring, which is the left segment, is constructed with use of a novel one-pot delta-lactonization protocol. Both segments are prepared from a common starting material, D-mannitol. These segments are then coupled and the functional groups are transformed to synthesize (+)-mycalamide A.
The details of a convergent total synthesis of (+)-mycalamide A are described. Yb(OTf)3−TMSCl-catalyzed cross-aldol reaction conditions are used to synthesize the right segment of mycalamide A. In this reaction, an acid-sensitive aldehyde reacts with methyl trimethylsilyldimethylketeneacetal without epimerization to provide the desired aldol adduct. Additionally, a tetrahydropyran ring, which is
A convergent total synthesis of (+)-mycalamide A is described. A Yb(OTf)(3)-TMSCI catalytic system is used to synthesize a trioxadecalin ring system, which contains the right segment of mycalamide A. In addition, a tetrallydropyran ring, which is the left segment, is constructed with use of a novel one-pot delta-lactonization protocol. Both segments are prepared from a common starting material, D-mannitol. These segments are then coupled and the functional groups are transformed to synthesize (+)-mycalamide A.